# Gland Pharma Limited – FDA Inspection, Nov 1, 2019

Source: https://www.keypedia.com/records/fda_inspections/gland-pharma-limited/dcb210ce-c362-4c32-9e94-f2665152f61b
Source feed: FDA_Inspections

> FDA inspection 1110628 of Gland Pharma Limited, November 01, 2019. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1110628
- Company Name: Gland Pharma Limited
- Inspection Date: 2019-11-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1220251 - 2023-07-28
- FDA Inspection 1061075 - 2018-06-15
- FDA Inspection 1056489 - 2018-05-18
- [FDA Inspection 1010051 - 2017-03-31](https://www.keypedia.com/records/fda_inspections/gland-pharma-limited/f11bc613-6f2c-4144-ad0f-51acc97a860d)
- FDA Inspection 936901 - 2015-06-30

Company: https://www.keypedia.com/companies/gland-pharma-limited/9d02bb1e-32f9-45c5-9b90-f52622553c63

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
